The diabetes care company DexCom (DXCM) has announced a stock split of 4-for-1, increasing its total share count from 200M to 800M. DXCM is looking to grow their revenues by 15%-20% in 2022 by announcing their new G7 continuous glucose monitor.
ETF Newz Says:
The three ETFs with the most exposure to DXCM are: First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) with 7.86%, the Global X Internet of Things ETF (SNSR) with 4.80%, and the Fidelity Digital Health ETF (FDHT) with 3.59%.
